Trade Aligos Therapeutics, Inc. - ALGS CFD

Trading Conditions

• Type: CFD
• Spread: 0.1652
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 7.2724
• Open: 7.1324
• 1-Year Change: -38.6%
• Day's Range: 6.7924 - 7.3424

What is Aligos Therapeutics, Inc. (ALGS)?

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel therapies for viral diseases and liver-related conditions. The company’s research focuses on innovative drug candidates targeting chronic viral infections and associated liver diseases. Aligos Therapeutics employs a pipeline approach that includes small molecules and oligonucleotide therapeutics designed to address unmet medical needs. The company conducts clinical trials to evaluate the safety and efficacy of its investigational products. Its scientific efforts are supported by collaborations with academic and industry partners. Aligos Therapeutics aims to advance treatments that may improve patient outcomes in areas such as hepatitis and other viral infections. The company operates within the biotechnology sector, emphasizing translational research and clinical development.

Aligos Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by current trading conditions for Aligos Therapeutics, Inc., which is valued at $6.9576. The intraday range lies between $6.8124 and $7.3924, reflecting a daily change of -5.7437%.

FAQ: Aligos Therapeutics, Inc. (ALGS)

What is the current price of ALGS stock?

Aligos Therapeutics, Inc. is trading at $6.9576.

Does ALGS pay dividends?

Aligos Therapeutics, Inc. does not pay dividends.

Does ALGS have a formal corporate presence or regional headquarters in the UAE?

Aligos Therapeutics, Inc. operates in the UAE only through partners without an official office or subsidiary.

What is ALGS best known for?

Aligos Therapeutics, Inc. is most famous for developing therapies for liver diseases and cancer.

What assets are typically shown together with ALGS?

Commonly shown alongside ALGS: Western Alliance Bancorp, Regeneron Pharmaceuticals, Inc., Codexis